Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

An Erythrocyte Membrane-Associated Antigen, PvTRAg-26 of Plasmodium vivax

A Study of Its Antigenicity and Immunogenicity

Bibliographic Data

ID22069718
AuthorsLiping Fan (0009-0008-8433-3123, Anhui Medical University), Jinxing Xia (0000-0002-1559-0205, First Affiliated Hospital of Anhui Medical University), Jilong Shen (0000-0002-4755-3687, Anhui Medical University), Qiang Fang (0000-0002-0715-2184, Bengbu Medical College), Hui Xia (0009-0004-5941-5427, Bengbu Medical College), Meijuan Zheng (0000-0002-7378-3355, Anhui Medical University), Jin-Hee Han (Kangwon National University), Eun‐Taek Han (0000-0003-1962-7199, Kangwon National University), Eun-Taek Han, Bo Wang (0000-0002-0290-2134, Anhui Medical University, corresponding author), Yuanhong Xu (0000-0003-1549-9820, First Affiliated Hospital of Anhui Medical University, corresponding author)
Year2020
Volume8
Pages148-148
Publication date2020-04-28
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2020.00148
PMID32411650
OpenAlexW3023594329
LanguageEN
References cited62

Background: Plasmodium tryptophan-rich (TR) proteins have been proposed as potential vaccine candidate antigens. Among them, P. vivax tryptophan-rich antigens (PvTR-Ags), which have positionally conserved tryptophan residues in a TR domain, are highly antigenic in humans. Several of these antigens, including PvTRAg-26, have exhibited erythrocyte-binding activities. Methods: Subclasses of IgG antibodies against PvTRAg-26 were detected by enzyme-linked immunosorbent assay in 35 P. vivax infected patients and mice immunized with the recombinant antigen to characterize its antigenicity and immunogenicity. Moreover, the antigen-specific immune responses and Th1/Th2-type cytokine patterns of splenocytes from the immunized animals were determined in vitro. The subcellular localization of PvTRAg-26 in ring-stage parasites was also detected by indirect immunofluorescence assay. Results: The IgG1 and IgG3 levels in P. vivax-infected patients were significantly higher than those in uninfected individuals. In the PvTRAg-26-immunized mice, elevated levels of antigen-specific IgG antibodies were observed, dominated by the IgG1 subclass, and Th1-type cytokines were remarkably increased compared with Th2-type cytokines. Additionally, the subcellular location of the PvTRAg-26 protein was closely associated with the caveola-vesicle complex on the infected-erythrocyte membrane in the early ring stage of P. vivax. Conclusions: PvTRAg-26, a P. vivax TR antigen, with high antigenicity and immunogenicity, induces Th1-cytokine response and increases production of IgG1 antibodies. This immune profiling study provided a substantial evidence that PvTRAg-26 may be a potential candidate for P. vivax vaccine development

Antibody · Antigen · Antigenicity · Biology · Immune system · Immunogenicity · Immunoglobulin G · Malaria · Plasmodium falciparum · Plasmodium vivax · HIV Research and Treatment · Malaria Research and Control · Trypanosoma species research and implications · Immunology · Virology

Citation velocityhistorical
Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae